263
Participants
Start Date
April 30, 1994
Primary Completion Date
September 30, 2003
Study Completion Date
May 31, 2005
psychosocial assessment and care
Evaluate psychosocial function at prestudy, 6 months after starting treatment on S9133, and annually at 1-7 years after starting treatment on S9133.
quality-of-life assessment
Evaluate quality of life at prestudy, 6 months after starting treatment on S9133, and annually at 1-7 years after starting treatment on S9133.
Beth Israel Medical Center, New York
State University of New York - Upstate Medical University, Syracuse
University of Tennessee, Memphis Cancer Center, Memphis
University of Iowa Hospitals and Clinics, Iowa City
Barnes-Jewish Hospital, St Louis
Ellis Fischel Cancer Center - Columbia, Columbia
Walter Reed Army Medical Center, Washington D.C.
University of Massachusetts Memorial Medical Center, Worcester
Roswell Park Cancer Institute, Buffalo
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem
Rhode Island Hospital, Providence
National Cancer Institute (NCI)
NIH
Cancer and Leukemia Group B
NETWORK
SWOG Cancer Research Network
NETWORK